Figure 4B, on the other hand, compares the individuals who began using insulin more than six months after diagnosis, including the patients classified as T2DM according to the criteria published by Shields et al. [4], and the majority of the patients with MODY. This evidence concerns the gene INS and type 2 diabetes mellitus.